Seoul Court Maintains Stance Not To Raise Novartis' Glivec Price; Health Ministry May Appeal To Higher Court
This article was originally published in The Pink Sheet Daily
Executive Summary
A mandated price cut for imatinib goes against "fairness" and the purpose of the EU free trade agreement, the court said.